
Opinion|Videos|March 28, 2025
Looking Ahead: Future Landscape for Treating OFF Time and Dyskinesia
Author(s)Daniel E. Kremens, MD, JD
An expert discusses D1 receptor agonists that reduce negative symptoms and the increasing availability of recent and upcoming PUMP options for Parkinson disease treatment.
Advertisement
Episodes in this series

Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
FDA Approves Tau PET Tracer MK-6240 for Alzheimer Diagnostic Workup
2
CN045 Promotes Oligodendrocyte Maturation, Modest Remyelination in Preclinical MS Study
3
FDA Clears Phase 2 Trial for Demyelinating Agent Lucid-MS in Progressive Multiple Sclerosis
4
Ractigen Completes Phase 2 Enrollment for RAG-17 in SOD1-ALS
5
















